BVF »

Monte Rosa Therapeutics shares owned by BVF

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by BVF from 13F filings

Historical chart of BVF investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by BVF

Quarter filed Position value Share count Share price at filing
2025-09-30 $42M 5.7M 7.41
2025-06-30 $26M 5.7M 4.51
2025-03-31 $26M 5.7M 4.64
2024-12-31 $19M 2.8M 6.94

More positions owned by BVF

Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Cidara Therapeutics Com New (CDTX)
Gh Research Ordinary Shares (GHRS)
Mirum Pharmaceuticals (MIRM)
Xoma Royalty Corporation Com New (XOMA)
Structure Therapeutics Sponsored Ads (GPCR)
Kura Oncology (KURA)
Septerna (SEPN)
Palvella Therapeutics Inc Ne (PVLA)
Nektar Therapeutics Com New (NKTR)
Zymeworks Del (ZYME)
Axsome Therapeutics (AXSM)

View all positions for BVF

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics